Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-07-21Clinical Trial Update: Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients [Phase 4]
Phase 4 trial evaluating the efficacy and safety of valdecoxib compared with naproxen for the signs and symptoms of rheumatoid arthritis in …
-
CLINICAL_TRIALS trial_result · 2008-07-11Clinical Trial Update: Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) [Phase 2]
Phase 2 efficacy study of MM-093 in rheumatoid arthritis patients on methotrexate has completed; results are not provided in the snippet.
-
EMA guidance · 2008-06-26EMEA recommends strengthening warnings and contraindications for etoricoxib-containing medicines used in the treatment of rheumatoid arthritis and ankylosing spondylitis
EMA recommends stronger warnings and contraindications for etoricoxib-containing medicines used to treat rheumatoid arthritis and ankylosing…
-
FDA approval · 2008-06-20FDA Approved: JUNIOR STRENGTH ADVIL — Supplemental Application (Haleon US Holdings LLC)
FDA approves a supplemental application for JUNIOR STRENGTH ADVIL (ibuprofen) from Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2008-06-12Clinical Trial Update: Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? [Phase 4]
A Phase 4 trial evaluating Humira (adalimumab) for rheumatoid arthritis and potential healing of bone erosions has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-05-30Clinical Trial Update: Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis [Phase 2]
A Phase 2 randomized trial comparing long-circulating liposomal prednisolone to pulse intramuscular methylprednisolone in patients with acti…
-
CLINICAL_TRIALS trial_result · 2008-05-28Clinical Trial Update: The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis [Phase 1, Phase 2]
The trial updates indicate completion of a Phase 1/2 study evaluating an anti-CD4 monoclonal antibody fragment for imaging chronic inflammat…
-
CLINICAL_TRIALS research · 2008-05-09Clinical Trial Update: An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis [Phase 2]
This document documents a Phase 2 clinical trial update from the Chinese University of Hong Kong evaluating peripheral blood T cell subsets …
-
CLINICAL_TRIALS trial_result · 2008-05-09Clinical Trial Update: Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis [Phase 2]
Phase 2 trial evaluating the traditional Chinese medicine combination Lingzhi and Sen Miao San for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-09Clinical Trial Update: Acupuncture for the Treatment of Rheumatoid Arthritis [Phase 2]
This update notes the completion of a Phase 2 clinical trial evaluating acupuncture for rheumatoid arthritis conducted by the Chinese Univer…
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. [Phase 3]
A completed Phase 3 trial compared PN 200 with naproxen to evaluate the incidence of gastric ulcers in subjects at risk for NSAID-associated…
-
CLINICAL_TRIALS approval · 2008-04-14Clinical Trial Update: Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
Adalimumab has received marketing approval for active rheumatoid arthritis under an early access program.
-
FDA approval · 2008-04-07FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Orencia (abatacept) submitted by E.R. Squibb & Sons, L.L.C., resulting in an update to its l…
-
CLINICAL_TRIALS approval · 2008-04-01Clinical Trial Update: Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
Abbott announced marketing approval for a human anti-TNF monoclonal antibody for active rheumatoid arthritis.
-
CLINICAL_TRIALS approval · 2008-04-01Clinical Trial Update: Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab
Adalimumab has received marketing approval for rheumatoid arthritis following an open-label efficacy and safety assessment.
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating subcutaneous adalimumab in adult Chinese rheumatoid arthritis pa…
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial evaluating whether adalimumab alters immune responses to influenza and pneumococcal vaccines in rheumatoid arthritis;…
-
CLINICAL_TRIALS trial_result · 2008-03-31Clinical Trial Update: A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis [Phase 2, Phase 3]
Clinical trial update on the evaluation of adalimumab in adult Japanese patients with rheumatoid arthritis, spanning Phase 2 and Phase 3, wi…
-
CLINICAL_TRIALS trial_result · 2008-03-27Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis [Phase 2]
A completed Phase 2 trial evaluating 60 mg MM-093 in patients with active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2008-03-21Clinical Trial Update: Ancillary Study to Protocol 20060104
An ancillary study to protocol 20060104 sponsored by Amgen in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-11Clinical Trial Update: Assessment of the Effectiveness of Low-Level Laser Therapy on the Hands of Patients With Rheumatoid Arthritis [NA]
A completed clinical trial evaluating the effectiveness of low-level laser therapy on the hands of patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2008-03-07Clinical Trial Update: Meditation-Based Stress Reduction in Rheumatoid Arthritis [Phase 2]
Phase 2 trial evaluating meditation-based stress reduction for rheumatoid arthritis has completed. The update summarizes the study results.
-
FDA approval · 2008-03-07FDA Approved: NABUMETONE — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Nabumetone as a generic product under an original ANDA submitted by Exelan Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2008-03-05Clinical Trial Update: Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NIAMS-sponsored clinical trial update reports completed genetic and immune studies investigating rheumatoid arthritis, psoriatic arthritis, …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept [Phase 2]
A Phase 2 clinical trial studied the role of cytokines in growth hormone suppression in premenopausal women with rheumatoid arthritis and ev…